UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019369
Receipt number R000022396
Scientific Title Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer
Date of disclosure of the study information 2015/10/15
Last modified on 2015/10/15 21:01:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer

Acronym

Ovarian reserve evaluation in gynecologic conditions

Scientific Title

Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer

Scientific Title:Acronym

Ovarian reserve evaluation in gynecologic conditions

Region

Japan


Condition

Condition

endometrioma

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of ovarian reserve using serum AMH levels after surgery for endometriomas

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum AMH levels one month before treatment, and 1,12 months afer treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Measurement of serum AMH levels one month before surgery and 1,12 months after surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Female

Key inclusion criteria

> 4-cm endometrioma at one side at least

Key exclusion criteria

possible ovarian cancer

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Iwase

Organization

Nagoya University School of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2261

Email

akiwase@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akira Iwase

Organization

Nagoya University School of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2261

Homepage URL


Email

akiwase@med.nagoya-u.ac.jp


Sponsor or person

Institute

Obstetrics and Gynecology, Nagoya University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Obstetrics and Gynecology, Nagoya University School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 08 Month 13 Day

Date of IRB


Anticipated trial start date

2009 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 15 Day

Last modified on

2015 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022396


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name